A consultation about a West Midlands Local Growth Plan.

By David Kidney

The West Midlands Combined Authority is asking us all for our views before producing a first Local Growth Plan. The Combined Authority has launched the West Midlands Futures Green Paper and you ought to consider having your say about what needs to be in the Growth Plan. 

Life sciences can be a major driver of inclusive and transformative growth in the West Midlands. The life sciences sector is not only about health—it’s about wealth, innovation, and resilience. If we want truly inclusive growth, we must position the West Midlands as a national leader in health and life sciences.

Local Growth Plans are the Government’s idea. It plans to produce a National Industrial Strategy soon and it wants local authorities like the West Midlands Combined Authority (WMCA) to produce Local Growth Plans to complement that national strategy but also reflect regional strengths and variations.

To give WMCA credit, the West Midlands Futures Green Paper is actively trying to generate a conversation with us all about our region’s long-term priorities. 

Growth is described as “the golden thread” running through the Green Paper.  And by “growth”, WMCA means inclusive growth, what the Mayor calls “Growth for Everyone”. 

In the West Midlands, we have what it takes to be an economically prosperous region in terms of our size and scale, the youthfulness, diversity and dynamism of our population, our record on investment and innovation, and our connectivity. 

The West Midlands’ economy is not yet at its full potential. A £77bn economy, 3.5% of the national economy, would be boosted by £12bn if productivity were just raised to the UK average. And the Green Paper is very positive that we can do this. As an accompanying paper called The Theory of Growth says, “Economic transformation is possible”.

Life sciences—and particularly HealthTech—can be a cornerstone of the West Midlands’ growth strategy. The region already boasts strong research institutions, a growing medtech ecosystem, and NHS partnerships ripe for innovation. By prioritising life sciences in the Local Growth Plan, the Combined Authority could unlock high-value jobs, support an aging population, and leverage digital innovation to drive both wellbeing and economic productivity.

This is especially relevant under the “public service innovation and people and skills” pillar. Health innovation doesn’t just improve lives—it creates new career paths, attracts investment, and can anchor local manufacturing and R&D capacity. Aligning the Growth Plan with our region’s health innovation strengths ensures we’re building an economy that’s both future-facing and fair.

The Green Paper sets out four big areas of change on the horizon and how regional stakeholders are beginning to respond to them: 

  • The first West Midlands Growth Plan
  • A regional spatial development strategy with key investment sites 
  • Public service innovation and people and skills 
  • A new five-year plan for net zero.

In each area, the Green Paper sets out a handful of questions, there are 20 questions in all. Your opinions about the direction of travel and how we seize the many opportunities we have before us could influence the final content of the Combined Authority’s Growth Plan.  

But you will have to hurry if you want to take part. The closing date for responses is 8th June.

To have your say, visit the Combined Authority’s website: https://tinyurl.com/7cz6v27e

And just to confirm, yes, I have responded, drawing attention to the key HealthTech considerations.

David Kidney, Executive Chair, West Midlands Health Technologies Cluster

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details